Illumina Inc. closed $13.90 short of its 52-week high ($144.02), which the company achieved on January 31st.

On Thursday, Illumina Inc (ILMN) stock saw a modest uptick, ending the day at $132.27 which represents a slight increase of $6.12 or 4.85% from the prior close of $126.15. The stock opened at $128.04 ...

The stock's rise snapped a four-day losing streak.

We recently compiled a list of the 35 Non-Tech Stocks With Long-Term Investment Potential. In this article, we are going to ...

GRAIL faces financial challenges but holds significant growth potential with its Galleri cancer-screening test. Click here to ...

Illumina Inc (ILMN) stock saw a decline, ending the day at $128.82 which represents a decrease of $-1.28 or -0.98% from the prior close of $130.1. The stock opened at $130.49 and touched a low of $128 ...

Check the time stamp on this data. Updated AI-Generated Signals for Illumina Inc. (ILMN) available here: ILMN.

Non-Tech AI Opportunities. In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against ...

Investors have poured billions of dollars into the "liquid biopsy" space for the early detection and tracking of cancer. Now ...

Genomics is on the brink of revolutionizing healthcare with breakthroughs that could redefine treatment and diagnosis. As ...

在最近的财经新闻中，代表德克萨斯州第26国会选区的Michael C. Burgess在股票市场进行了一笔重要交易。这笔交易涉及的公司是基因组学行业的领先企业Illumina, Inc. (NASDAQ:ILMN)。 根据众议院书记官发布的定期交易报告，Burgess出售了其持有的部分Illumina, Inc.股票。这笔交易发生在2024年9月3日，正式通知日期为2024年9月5日。 交易的财务 ...

Fulcrum is developing another pipeline candidate, pociredir, in an early-stage study for treating patients with sickle cell ...